Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Letters to the Editor

Evidence for an Association between JC Virus and Colorectal Neoplasia

C. Richard Boland
C. Richard Boland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published December 2004
  • Article
  • Info & Metrics
  • PDF
Loading

To the Editor: Newcomb et al. (1) have attempted to confirm the presence of JC virus (JCV) DNA in colorectal cancers and have failed to do so. They reached their negative conclusion, although other groups have been able show JCV in colonic epithelium and colorectal neoplasia (2-4). Whether this polyomavirus, which encodes a'potent oncogene (T antigen), causes colon cancer remains an open question. However, its presence in colonic tissues and colorectal neoplasms in particular is not a question. This has been reported convincingly from two laboratories.

Our group has repeatedly confirmed this observation on different specimens of colorectal cancer (published and unpublished), each time using multiple controls to ensure the absence of PCR contamination. The assay is somewhat technically difficult and requires a focused effort by a dedicated laboratory to perfect. We began work on this project in 1994, and although the initial experiments were positive, we took several months to optimize the PCR conditions. JCV is a small circular DNA virus and may be present in relatively small amounts in colorectal neoplasms. Newcomb et al. used novel primers and an entirely different method for their assays. Specifically, all of their assays were done on DNA extracted from formalin-fixed, paraffin-embedded specimens. We initially had some difficulty performing JCV PCR from paraffin. The formalin fixation breaks DNA and may make it more difficult to recover sufficient quantities of intact JCV DNA for amplification. Newcomb et al. may have had difficulty with PCR amplification of JCV out of paraffin as well. In fact, they reported no positive controls in which they were able to get this PCR to work from paraffin tissues. They readily obtained PCR products from a plasmid preparation or urine samples, much the same way we have readily obtained PCR evidence for JCV from frozen specimens that have never been fixed in formalin. The only positive PCR result obtained from the 233 fixed tissues by Newcomb et al. was not confirmed either by Southern blot or DNA sequencing; even this may have been a nonspecific result.

Essentially, Newcomb et al. have attempted to use an assay that had not undergone appropriate, relevant validation and speculated that their failure to obtain PCR products refutes multiple lines of evidence from other laboratories. A BLAST analysis indicates that the 'T-antigen primers in this study form multiple primer dimers which would almost certainly limit the PCR efficiency. Moreover, other primers were found to have complete sequence matches with BK virus as well as JCV suggesting that the primer design was not optimal.

It is unlikely that the results from our laboratory rep resent assay contamination because of the DNA sequence variations we have found in the T antigen and in the transcription control region. Contamination is likely to provide a uniform product. Moreover it is extremely unlikely (and would be unprecedented) that the rearrangements in the transcription control region reported by Ricciardiello et al. (5) represent PCR artifacts, as these sequence alterations are additions or deletions of a 98-bp cassette; similar rearrangements are generated during viral replication in nature and have been found in human samples by others (6, 7). The authors' suggestion that our'PCR amplification of JCV represents nonspecificity due to the use of degenerate primers makes little sense, as our PCR products were validated both by Southern blot and by DNA sequencing. In addition, Enam et al. (4) have confirmed our findings, and extended these, by demonstrating protein expression of the T antigen and agnoprotein in colon cancers, but not normal colon, using immunohistochemistry. This important confirmation was dismissed without consideration by Newcomb et al. Considering the work of two independent laboratories, it is difficult to accept that a novel, unvalidated assay is sufficient to conclude that the prior investigators have been inaccurate.

It is reasonable for Newcomb et al. to conclude that they are unable to document the presence of JCV using their approach on paraffin-embedded tissues. The assay developed by our group and Khalili's group took considerable effort to validate. The best explanation for Newcomb et al.'s findings is that they have not made the assay sufficiently sensitive to find JCV DNA sequences that are actually present.

References

  1. ↵
    Newcomb PA, Bush AC, Stoner GL, Lampe JW, Potter JD, Bigler J. No evidence of an association of JC virus and colon neoplasia. Cancer Epidemiol Biomarkers Prev 2004;13:662–6.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Laghi L, Randolph AE, Chauhan DP, et al. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci U S A 1999;96:7484–9.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Ricciardiello L, Laghi L, Ramamirtham P, et al. JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract. Gastroenterology 2000;119:1228–35.
    OpenUrlCrossRefPubMed
  4. ↵
    Enam S, Del Valle L, Lara C, et al. Association of human polyomavirus JCV B with colon cancer: evidence for interaction of viral T-antigen and β-catenin. Cancer Res 2002;62:7093–101.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Ricciardiello L, Chang DK, Laghi L, Goel A, Chang CL, Boland CR. Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-pair sequence in colon cancer tissues. J Virol 2001;75:1996–2001.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Yogo Y, Kitamura T, Sugimoto C, et al. Sequence rearrangement in JC virus DNAs molecularly cloned from immunosuppressed renal transplant patients. J Virol 1991;65:2422–8.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Yogo Y, Guo J, Iida T, et al. Occurrence of multiple JC virus variants with distinctive regulatory sequences in the brain of a single patient with progressive multifocal leukoencephalopathy. Virus Genes 1994;8:99–105.
    OpenUrlCrossRefPubMed

In Response: Dr. C. Richard Boland raises concerns about the ability of our study to detect an association between JC virus and colorectal cancer. Our data do suggest that it can be present in colon, albeit at much lower frequency than his group (1, 2) and Enametal.(3)report. However, in our opinion, neither their data nor ours support a role of JC virus as a cause of colon cancer (4). Ricciardiello et al. (2) report a high prevalence of JC virus in gastric and colonic tissue from patients without gastrointestinal neoplasia (>70% of participants). In our study, the prevalence of JCvirus was <0.005% in normal tissue from colorectal cancer patients.

The cause of the large difference in JC virus prevalence probably is due to technical issues. Blast searches done atthe time we designed the primers as well as Blast searches done now did not indicate homologies between our PCR primers and BKV sequences, as suggested by Dr.Boland. Our primers and probes were designed using PrimerExpress (Applied Biosystems, Foster City, CA), which eliminates primers pairs that are likely to form dimers.

In our assay design, we did take into account the lower quality of DNA from paraffin-embedded tissue we were testing by designing shorter amplicons (100-150 bp), which amplify well even from degraded DNA. As we explained in the Discussion section of our article, we had no problems amplifying 10 markers of similar size in single-copy genes from these DNAs and have no reason to believe that the DNA contained contaminants that inhibited amplification. We also screened DNA from normal, fresh frozen colon biopsies from 80 individuals, none of which turned out to be JC virus positive. Furthermore, their report that Mad-1 is the exclusive JC virus strain found in the human colon (5) is not consistent with our finding of a colonic isolate that did nothave a rearranged regulatory region. This fact was not stated clearly enough in our article and we are grateful to Dr. Boland for an opportunity to make up for this omission.

Our criteria for a “JC virus positive” call were more stringent than those of Laghi et al. (1). Samples were classified positive only if we could obtain sequence for at least two of the three fragments tested, whereas in Laghi et al. (1) one positive amplification of an average of four amplifications per sample led to a positive call. This difference alone would have an effect on the proportion of positive calls.

Dr. Boland argues that the presence in their study of different JC virus sequences within an individual speaks against contamination with their positive control. Although it is well known that Taq polymerase is error prone (6), this is not usually a problem when direct sequencing PCR products but will become noticeable when cloning PCR products and then sequencing individual clones, especially when starting with a small copy number of template (6). In such a case, it is essential to sequence numerous clones to obtain a consensus sequence. Thus, the sequence differences in clones derived from the same patient as reported by Dr.Boland's group (1, 2, 5) are much more likely due to errors introduced during PCR amplification than intraindividual variation. Unfortunately, direct sequencing of some of their PCR fragments does not seem possible because of other fragments that are coamplified in their PCRs (see figures in refs. 1, 2, 7). Our amplifications, however, were optimized to allow direct sequencing, which is preferable to Southern hybridization as a tool for sequence verification. We agree that the 98-bp deletion in their clones is not likely due to PCR artifacts. However, because this region is prone to rearrangements, it is very conceivable that such rearrangements occur while growing up the clones. A comparison of direct sequencing of the PCR fragment before cloning and sequencing individual clones afterward could address this question.

In summary, the reports from Dr. Boland's group had some important limitations. The intraindividual sequence heterogeneity on the one hand and the finding of the same strain in different individuals on the other (5) are not consistent with other published work: (a) longitudinal studies that show shedding of the same JC virus strain (8), (b) extensive work on the geographic distribution of different JC virus strains (e.g., ref. 9), and (c) and uniqueness of rearrangements of neurotropic JC virus isolates from different individuals (e.g., ref. 10).

References

  1. ↵
    Laghi L, Randolph AE, Chauhan DP, et al. JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci U S A 1999;96:7484–9.
  2. ↵
    Ricciardiello L, Laghi L, Ramamirtham P, et al. JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract. Gastroenterology 2000;119:1228–35.
  3. ↵
    Enam S, Del Valle L, Lara C, et al. Association of human polyomavirus JCV with colon cancer: evidence for interaction of viral T-antigen and b-catenin. Cancer Res 2002;62:7093–101.
  4. ↵
    Blaho JA, Aaronson SA. Convicting a human tumor virus: guilt by association? Proc Natl Acad Sci U S A 1999;96:7619–21.
    OpenUrlFREE Full Text
  5. ↵
    Ricciardiello L, Chang DK, Laghi L, Goel A, Chang CL, Boland CR.Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-pair sequence in colon cancer tissues. J Virol 2001;75:1996–2001.
  6. ↵
    Saiki RK. The design and optimization of the PCR. In: Erlich HA, editor. PCR technology: principles and applications for DNA amplification. New York: Stockton Press; 1989. p. 7–16.
  7. ↵
    Ricciardiello L, Baglioni M, Giovanini C, et al. Induction of chromosomal instability in colonic cells by the human polyomavirus JC virus. Cancer Res 2003;63:7256–62.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Kitamura T, Sugimoto C, Kato A, et al. Persistent JC virus (JCV) infection is demonstrated by continuous shedding of the same JCV strains. J Clin Microbiol 1997;35:1255–57.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Agostini HT, Jobes DV, Stoner GL. Molecular evolution and epidemiology of JC virus. In: Khalili K, Stoner GD, editors. Human polyomaviruses: molecular and clinical perspectives. Hoboken (NJ): Wiley-Liss, Inc.; 2001. p. 491–526.
  10. ↵
    Agostini HT, Ryschkewitsch CF, Singer EJ, Stoner GL. JC virus regulatory region rearrangements and genotypes in progressive multifocal leukoencephalopathy: two independent aspects of virus variation. J Gen Virol 1997;78:659–64.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 13 (12)
December 2004
Volume 13, Issue 12
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evidence for an Association between JC Virus and Colorectal Neoplasia
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Evidence for an Association between JC Virus and Colorectal Neoplasia
C. Richard Boland
Cancer Epidemiol Biomarkers Prev December 1 2004 (13) (12) 2285-2286;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Evidence for an Association between JC Virus and Colorectal Neoplasia
C. Richard Boland
Cancer Epidemiol Biomarkers Prev December 1 2004 (13) (12) 2285-2286;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
    • References
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Copy Number Variation and Ovarian Cancer Risk—Letter
  • Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer Risk—Response
  • Shift Work, Chronotype, and Cancer Risk—Response
Show more Letters to the Editor
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement